Your browser doesn't support javascript.
loading
Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study.
Wang, Yuxi; Chew, Qian Hui; Lin, Shih-Ku; Yang, Shu-Yu; Ouyang, Wen-Chen; Chen, Chih-Ken; Park, Seon-Cheol; Jang, Ok-Jin; Park, Jun Hyuk; Chee, Kok-Yoon; Ding, Kwong Sen; Chong, Jamaline; Zhang, Ling; Li, Keqing; Zhu, Xiaomin; Jatchavala, Chonnakarn; Pariwatcharakul, Pornjira; Kallivayalil, Roy Abraham; Grover, Sandeep; Avasthi, Ajit; Ansari, Moin; Maramis, Margarita M; Aung, Paing Phyo; Sartorius, Norman; Xiang, Yu-Tao; Tan, Chay-Hoon; Chong, Mian-Yoon; Park, Yong Chon; Kato, Takahiro A; Shinfuku, Naotaka; Baldessarini, Ross J; Sim, Kang.
Affiliation
  • Wang Y; From the West Region, Institute of Mental Health.
  • Chew QH; Research Division, Institute of Mental Health, Singapore.
  • Yang SY; Department of Pharmacy, Taipei City Hospital, Taipei.
  • Chen CK; Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan.
  • Jang OJ; Department of Psychiatry, Bugok National Hospital, Changnyong.
  • Park JH; Jeju National University Hospital, Jeju University School of Medicine, Jeju, Korea.
  • Chee KY; Department of Psychiatry & Mental Health, Tunku Abdul Rahman Institute of Neurosciences, Kuala Lumpur Hospital, Kuala Lumpur.
  • Ding KS; Department of Psychiatry, Hospital Bahagia Ulu Kinta, Tanjung Rambutan, Perak Darul Ridzwan.
  • Chong J; Hospital Permai Johor Bahru, Ministry of Health, Johor Bahru, Malaysia.
  • Zhang L; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, School of Mental Health, Capital Medical University, Beijing.
  • Li K; Hebei Provincical Mental Health Center, Baoding, Hebei.
  • Zhu X; Department of Psychiatry, Suzhou Guangji Hospital, the Affiliated Guangji Hospital of Soochow University, Suzhou, China.
  • Jatchavala C; Department of Psychiatry, Faculty of Medicine, Prince of Songkla University, Songkhla.
  • Pariwatcharakul P; Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Kallivayalil RA; Department of Psychiatry, Pushpagiri Institute of Medical Sciences, Tiruvalla.
  • Grover S; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Avasthi A; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Ansari M; Department of Psychiatry, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
  • Maramis MM; Department of Psychiatry, Dr Soetomo Hospital-Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
  • Aung PP; Mental Health Hospital, Yangon University of Medicine, Yangon, Myanmar.
  • Sartorius N; Association for the Improvement of Mental Health Programs, Geneva, Switzerland.
  • Tan CH; Department of Pharmacology, National University of Singapore, Singapore.
  • Chong MY; Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and School of Medicine, Chang Gung University, Taoyuan City, Taiwan.
  • Park YC; Department of Neuropsychiatry, Hanyang University Guri Hospital, Guri, South Korea.
  • Kato TA; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University.
  • Shinfuku N; School of Human Sciences, Seinan Gakuin University, Fukuoka, Japan.
  • Baldessarini RJ; International Consortium for Mood and Psychotic Disorder Research, McLean Hospital, Belmont, Massachusetts and Department of Psychiatry, Harvard Medical School, Boston, MA.
J Clin Psychopharmacol ; 42(3): 293-297, 2022.
Article in En | MEDLINE | ID: mdl-35384905
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antipsychotic Agents / Bipolar Disorder Type of study: Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Humans / Male Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antipsychotic Agents / Bipolar Disorder Type of study: Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Humans / Male Language: En Year: 2022 Type: Article